Email Artikel ini HUMAN CATHELICIDIN ANTIMICROBIAL PEPTIDE LL-37 AS AN ANTIBACTERIA, ANTIFUNGAL, ANTIVIRAL AND WOUND HEALING AGENT
Abstrak
LL-37 is a cathelicidin-derived peptide in human. This protein contains two helical regions, an unstructured C-terminal tail and a cathionic amphiphatic charge. This review described the functions of human cathelicidin antimicrobial peptide LL-37. Cathelicidin peptides were shown to have some functions like to kill bacteria by distrupting the bacterial membranes of Staphylococcus aureus, Micrococcus luteus and Salmonella gastroenteritis, fungicidal against Candida albicans and Aspergillus sp , and work as antiviral agent against vaccinia virus by direct disruptive action on the viral envelope. Besides its antimicrobial effects, cathelicidins also play a role in wound healing through direct interaction or stimulation of the immune system, stimulating angiogenesis and re-epitheliazation. From the studies, it showed that LL-37 is a potential protein for the development of new drugs in the future.
Teks Lengkap:
PDF (English)Referensi
Li, Na., Kenshi Y., Rumiko Saito., Sawako F.T., Ryoko S.O., Masayuki A., dan Setsuya A. 2014. Alarmin Function of Cathelicidin Antimicrobial Peptide LL37 through IL-36g Induction in Human Epidermal Keratinocytes. The Journal of Immunology, 193: 5140–5148.
J.W. Larrick, M. Hirata, R.F. Balint, J. Lee, J. Zhong, S.C. Wright. 1995. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein, Infect. Immun. 63 : 1291–1297.
Vandamme, D., Bart L., Walter L., Liliane S.2012. A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cellular Immunology 280 : 22–35
Henzler Wildman, K. A., Lee, D.-K. & Ramamoorthy, A. 2003. Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. Biochemistry 42 (21) : 6545–6558,
Li, X., Li, Y., Han, H., Miller, D. W. & Wang, G. 2006. Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. J. Am. Chem. Soc. 128, 5776–5785.
Porcelli, F. et al. 2008. NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles. Biochemistry 47, 5565–5572.
Sorensen, O. E. et al. 2001. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97, 3951–3959.
Zanetti, M. 2004. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75, 39–48.
K. Hase, L. Eckmann, J.D. Leopard, N. Varki, M.F. Kagnoff, 2002. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect. Immun. 70 953– 963.
R. Bals, X. Wang, M. Zasloff, J.M. Wilson. 1998. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA 95 9541–9546.
N.M. Frohm, B. Sandstedt, O. Sorensen, G. Weber, N. Borregaard, M. Stahle-Backdahl.. 1999. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect. Immun. 67 2561–2566.
B.J. Kim, Y.K. Rho, H.I. Lee, M.S. Jeong, K. Li, S.J. Seo, M.N. Kim, C.K. Hong. 2009. The effect of calcipotriol on the expression of human beta defensin-2 and LL-37 in cultured human keratinocytes, Clin. Dev. Immunol. 645898.
Y.J. Gordon, L.C. Huang, E.G. Romanowski, K.A. Yates, R.J. Proske, A.M. McDermott. 2005. Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr. Eye Res. 30 385–394.
M. Murakami, B. Lopez-Garcia, M. Braff, R.A. Dorschner, R.L. Gallo. 2004. Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J. Immunol. 172 3070–3077.
H.W. Koon, D.Q. Shih, J. Chen, K. Bakirtzi, T.C. Hing, I. Law, S. Ho, R. Ichikawa, D. Zhao, H. Xu, R. Gallo, P. Dempsey, G. Cheng, S.R. Targan, C. Pothoulakis. 2011. Cathelicidin signaling via the Toll-like receptor protects against colitis in mice. Gastroenterology 141 1852–1863.
M.H. Braff, N.A. Di, R.L. Gallo. 2005. Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies. J. Invest. Dermatol. 124 : 394–400
J. Overhage, A. Campisano, M. Bains, E.C. Torfs, B.H. Rehm, R.E. Hancock. 2008. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect. Immun. 76 : 4176–4182.
J.H. Wong, T.B. Ng, A. Legowska, K. Rolka, M. Hui, C.H. Cho. 2011. Antifungal action of human cathelicidin fragment (LL13-37) on Candida albicans. Peptides 32 : 1996–2002.
J.H. Wong, A. Legowska, K. Rolka, T.B. Ng, M. Hui, C.H. Cho, W.W. Lam, S.W. Au, O.W. Gu, D.C. Wan. 2011. Effects of cathelicidin and its fragments on three key enzymes of HIV-1. Peptides 32 : 1117–1122.
R. Koczulla, D.G. von, C. Kupatt, F. Krotz, S. Zahler, T. Gloe, K. Issbrucker, P. Unterberger, M. Zaiou, C. Lebherz, A. Karl, P. Raake, A. Pfosser, P. Boekstegers, U. Welsch, P.S. Hiemstra, C. Vogelmeier, R.L. Gallo, M. Clauss, R. Bals. 2003. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111: 1665–1672.
M. Carretero, M.J. Escamez, M. Garcia, B. Duarte, A. Holguin, L. Retamosa, J.L. Jorcano, M.D. Rio, F. Larcher. 2008. In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37, J. Invest. Dermatol. 128 : 223–236
Kuroda K, Okumura K, Isogai H and Isogai E. 2015. The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs. Front. Oncol. 5:144.
Zhang X, Oglęcka K, Sandgren S, Belting M, Esbjörner E.K, Nordén B, Gräslund A. 2010. Dual functions of the human antimicrobial peptide LL-37—Target membrane perturbation and host cell cargo delivery. Biochimica et Biophysica Acta 1798 : 2201–2208.
Johansson J, Gudmundsson GH, Rottenberg ME, Berndt KD, Agerberth B. 1998. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 273(6):3718–24.
Turner, J., Y. Cho, N.N. Dinh, A.J. Waring, and R.I. Lehrer. 1998. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 42, 2206- 2214.
Kim, Soon-Ja., Renshu Q., Sung-Jin L., Hak-Kyo L., and Joong-Kook C. 2009. Antibacterial Activitiy of Recombinant hCAP18/ll37 Protein Secreted from Pichia pastoris. The Microbiological Sosicety of Korea 47 (3) : 1-5.
X. Li, Y. Li, H. Han, D.W. Miller, G. Wang. 2006. Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region, J. Am. Chem. Soc. 128 : 5776–5785.
S. Thennarasu, A. Tan, R. Penumatchu, C.E. Shelburne, D.L. Heyl, A. Ramamoorthy. 2010. Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37, Biophys. J. 98 : 248–257.
den Hertog AL, van Marle J, van Veen HA, Van’t Hof W, Bolscher JG, Veerman EC, Nieuw Amerongen AV. 2005. Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem. J. 388: 689–695
Mania D, Hilpert K, Ruden S, Fischer R, Takeshita N. 2010. Screening for antifungal peptides and their modes of action in Aspergillus nidulans. Appl. Environ. Microbiol. 76:7102–7108.
J.H. Wong, T.B. Ng, A. Legowska, K. Rolka, M. Hui, C.H. Cho. 2011. Antifungal action of human cathelicidin fragment (LL13-37) on Candida albicans, Peptides 32 : 1996–2002.
Soledad R. Ordonez,a Ilham H. Amarullah,a Richard W. Wubbolts,b Edwin J. A. Veldhuizen,a Henk P. Haagsmana. 2014. Fungicidal Mechanisms of Cathelicidins LL-37 and CATH-2 Revealed by Live-Cell Imaging. Antimicrobial Agents and Chemotherapy 58 (4) : 2240–2248.
Howell MD, Jones JF, Kisich KO, Streib JE, Gallo RL, Leung DY. 2004. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J Immunol ;172:1763–1767.
Tripathi, S., Tesfaldet Tecle., Anamika Verma., Erika Crouch., Mitchell White and Kevan L. H. 2013. The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins. Journal of General Virology 94, 40–49.
Diegelmann RF, Evans MC. 2004. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci : 9:283–9
Yang D, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, et al. 2000. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med;192:1069–74
Elssner A, Duncan M, Gavrilin M, Wewers MD. 2004. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J Immunol ;172:4987–94.
Tjabringa GS, Aarbiou J, Ninaber DK, Drijfhout JW, Sorensen OE, Borregaard N, et al. 2003. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol;171:6690–6.
Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, Gloe T, et al. 2003. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest;111:1665–72
Heilborn JD, Nilsson MF, Kratz G, Weber G, Sorensen O, Borregaard N, et al. 2003. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol;120:379–89
Carretero M, Escamez MJ, Garcia M, Duarte B, Holguin A, Retamosa L, et al. 2008. In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. J Invest Dermatol;128:223–36
DOI: https://doi.org/10.24198/jf.v16i1.17512
DOI (PDF (English)): https://doi.org/10.24198/jf.v16i1.17512.g8665
Refbacks
- Saat ini tidak ada refbacks.
Sitasi manajer:
Jurnal ini diindeks dalam:
Farmaka by Universitas Padjadjaran is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Copyright © 2013 Jurnal Farmaka - All Right Reserved